Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.



October 20, 2016

NEW YORK/GENEVA, OCTOBER 20, 2016—A new cholera control strategy using a single-dose oral vaccine instead of two doses could be sufficient in protecting against the deadly disease during an outbreak, according to a study published by international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontiéres (MSF) in the Lancet Global Health this week.

October 12, 2016

“The World Health Organization’s annual look at the global state of tuberculosis this year makes for a shockingly bad report card: countries are failing to diagnose and treat millions of people with TB, which caused 1.8 million deaths last year. Governments need to get their heads out of the sand and realize that TB is not a disease consigned to the 1800s; we see and treat TB in our clinics every day, and it’s a deadly threat to all of us.

September 21, 2016

"Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the United Nations’s (UN) Political Declaration Antimicrobial Resistance, which recognizes the need to address – at the highest political levels – the complex issue of drug-resistant infections, which affect people in every part of the world. Now, governments have the responsibility to turn these words into action and fully implement nationally-tailored plans and global commitments to combat antimicrobial resistance (AMR).

September 20, 2016

MSF calls on Pfizer to match GSK’s move and offer the humanitarian community the lowest global price for this lifesaving vaccine

September 19, 2016

“After years of fighting for children caught in crises and desperately in need of the pneumonia vaccine, Doctors Without Borders/Médecins Sans Frontières is relieved to see that GlaxoSmithKline (GSK) finally plans to reduce its vaccine price for humanitarian organizations. GSK is leading the way in this commitment to children who are experiencing the most horrific of circumstances, while Pfizer continues to hide behind excuses and offer only piecemeal approaches to the humanitarian community.

September 16, 2016

"The sustainable development goals (SDGs) adopted with much fanfare just a year ago seek to end HIV, tuberculosis, and malaria by 2030. The replenishment of the Global Fund is the first concrete action taken by the international community since the adoption of these goals, and therefore a first test of the world leaders' will to make them a reality. Failure to reach the relatively modest Global Fund's replenishment target would be a clear message that the SDGs were but empty promises to the millions who, every year, continue to suffer and die from HIV, tuberculosis, and malaria."

September 14, 2016

On September 14, The United Nations Secretary-General’s High-Level Panel (UNHLP) on Access to Medicines will publish a landmark report on promoting innovation for and access to lifesaving medical tools.

September 13, 2016

Click Here to Download the Report

Every day, Doctors Without Borders/Médecins Sans Frontières (MSF) staff confront significant gaps in the availability of medical tools to address the health needs of the people we aim to care for in crisis-affected communities in more than 60 countries. These gaps—which have persisted for as long as MSF has been in operation—contribute to preventable deaths and exacerbate ongoing humanitarian and medical crises.

September 06, 2016

After ten years of working in Shamwana, in Tanganyika Province in southern DRC, MSF handed over its activities to the MoH on August 12, 2016.

September 02, 2016

As the United States and other member countries of the G20 meet in Hangzhou, China, September 4-5, Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to address the failures of medical research and development (R&D) to deliver medicines, vaccines and diagnostics that match the health needs of people around the world instead of only focusing on the most lucrative products.